Lithocholic Acid (LCA) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Lithocholic Acid (LCA) antibodies (anti-Lithocholic Acid, anti-LCA) and diagnostic hapten-carrier conjugates BSA-Lithocholic Acid (LCA), OVA-Lithocholic Acid (LCA), KLH-Lithocholic Acid (LCA) antigens for Liver diseases LCA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-LCA-Ag01 | BSA-Lithocholic Acid (LCA) | 756 |
GMP-SMT-LCA-Ag02 | OVA-Lithocholic Acid (LCA) | 756 |
GMP-SMT-LCA-Ab01 | Anti-human Lithocholic Acid (LCA) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-LCA-Ab02 | Anti-human Lithocholic Acid (LCA) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-LCA-Ag01 |
Product Name | BSA-Lithocholic Acid (LCA) |
Target/Biomarker | Lithocholic Acid (LCA) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LCA-Ag02 |
Product Name | OVA-Lithocholic Acid (LCA) |
Target/Biomarker | Lithocholic Acid (LCA) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LCA-Ab01 |
Product Name | Anti-human Lithocholic Acid (LCA) mouse monoclonal antibody (mAb) |
Target/Biomarker | Lithocholic Acid (LCA) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LCA-Ab02 |
Product Name | Anti-human Lithocholic Acid (LCA) human monoclonal antibody (mAb) |
Target/Biomarker | Lithocholic Acid (LCA) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Lithocholic acid, also known as 3α-hydroxy-5β-cholan-24-oic acid or LCA, is a bile acid that acts as a detergent to solubilize fats for absorption. Bacterial action in the colon produces LCA from chenodeoxycholic acid by reduction of the hydroxyl functional group at carbon-7 in the "B" ring of the steroid framework.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.